Arduino A Mangoni Selected Research

dimethylargininase

11/2021	Overexpression of dimethylarginine dimethylaminohydrolase 1 protects from angiotensin II-induced cardiac hypertrophy and vascular remodeling.
1/2019	Inhibition of Dimethylarginine Dimethylaminohydrolase (DDAH) Enzymes as an Emerging Therapeutic Strategy to Target Angiogenesis and Vasculogenic Mimicry in Cancer.
10/2017	MiR-193b regulates breast cancer cell migration and vasculogenic mimicry by targeting dimethylarginine dimethylaminohydrolase 1.
3/2009	Dimethylarginine dimethylaminohydrolase regulation: a novel therapeutic target in cardiovascular disease.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Arduino A Mangoni Research Topics

Disease

19	Inflammation (Inflammations) 01/2022 - 04/2003
16	Chronic Obstructive Pulmonary Disease (COPD) 05/2022 - 01/2016
15	Rheumatoid Arthritis 06/2022 - 05/2011
13	Cardiovascular Diseases (Cardiovascular Disease) 01/2022 - 05/2002
12	COVID-19 11/2022 - 01/2020
11	Atherosclerosis 05/2022 - 05/2006
8	Neoplasms (Cancer) 11/2022 - 05/2011
7	Hypertension (High Blood Pressure) 01/2022 - 01/2005
7	Heart Failure 10/2021 - 10/2003
7	Cognitive Dysfunction 01/2021 - 07/2006
6	Dementia (Dementias) 01/2021 - 07/2006
6	Frailty 01/2021 - 05/2012
5	Stroke (Strokes) 01/2022 - 01/2002
5	Myocardial Infarction 01/2018 - 06/2010
4	Idiopathic Pulmonary Fibrosis 01/2021 - 01/2018
3	Chronic Renal Insufficiency 11/2021 - 01/2016
3	Fibrosis (Cirrhosis) 11/2021 - 06/2006
3	Vascular Diseases (Vascular Disease) 11/2019 - 01/2009
3	Chronic Disease (Chronic Diseases) 11/2019 - 01/2005
3	Renal Cell Carcinoma (Grawitz Tumor) 01/2018 - 01/2016
3	Asthma (Bronchial Asthma) 02/2016 - 11/2013
3	Drug-Related Side Effects and Adverse Reactions 05/2012 - 05/2007
2	Infections 07/2022 - 01/2022
2	Critical Illness (Critically Ill) 01/2022 - 04/2011
2	Ischemic Stroke 01/2022 - 05/2010
2	Coronary Artery Disease (Coronary Atherosclerosis) 11/2021 - 05/2020
2	Cardiomegaly (Heart Hypertrophy) 11/2021 - 02/2014
2	Malnutrition (Nutritional Deficiencies) 01/2021 - 01/2021
2	Connective Tissue Diseases (Connective Tissue Disease) 01/2021 - 10/2020
2	Necrosis 01/2021 - 01/2017
2	Obesity 01/2020 - 01/2020
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2020 - 01/2020
2	Melanoma (Melanoma, Malignant) 01/2020 - 01/2020
2	Proteinuria 01/2018 - 01/2016

Drug/Important Bio-Agent (IBA)

17	Biomarkers (Surrogate Marker)IBA 11/2022 - 04/2013
13	Arginine (L-Arginine)FDA Link 01/2022 - 01/2009
11	Pharmaceutical PreparationsIBA 11/2022 - 01/2005
11	N,N-dimethylarginine (asymmetric dimethylarginine)IBA 11/2021 - 05/2013
9	Methotrexate (Mexate)FDA LinkGeneric 01/2021 - 05/2012
8	Nitric Oxide (Nitrogen Monoxide)FDA Link 01/2021 - 03/2009
7	HomocysteineIBA 05/2022 - 05/2002
7	AntioxidantsIBA 04/2022 - 01/2016
6	Antirheumatic Agents (DMARD)IBA 01/2019 - 09/2013
6	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 09/2013 - 04/2007
5	EnzymesIBA 11/2022 - 01/2016
5	C-Reactive ProteinIBA 01/2022 - 04/2003
5	Sulfhydryl Compounds (Thiols)IBA 11/2020 - 04/2013
5	Nitric Oxide Synthase (NO Synthase)IBA 10/2020 - 01/2013
5	Folic Acid (Vitamin M)FDA LinkGeneric 11/2008 - 01/2005
4	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 05/2022 - 05/2020
4	dimethylargininaseIBA 11/2021 - 03/2009
4	Malondialdehyde (Propanedial)IBA 06/2021 - 06/2013
4	Glutathione (Reduced Glutathione)IBA 03/2021 - 05/2020
4	Biological ProductsIBA 01/2021 - 05/2013
4	LDL CholesterolIBA 01/2021 - 01/2005
4	Thiobarbituric Acid Reactive SubstancesIBA 10/2020 - 01/2016
4	Taurine FDA Link 10/2020 - 01/2016
4	Tryptophan (L-Tryptophan)FDA Link 10/2020 - 09/2016
4	KynurenineIBA 10/2020 - 09/2016
4	Proteins (Proteins, Gene)FDA Link 05/2020 - 01/2016
4	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2018 - 05/2011
4	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 11/2017 - 10/2003
3	Aryldialkylphosphatase (Paraoxonase)IBA 03/2022 - 01/2016
3	AlbuminsIBA 01/2022 - 01/2021
3	HomoarginineIBA 01/2022 - 11/2019
3	Aspartate Aminotransferases (Aspartate Transaminase)IBA 01/2022 - 01/2021
3	Reactive Oxygen Species (Oxygen Radicals)IBA 10/2021 - 01/2018
3	Antihypertensive Agents (Antihypertensives)IBA 01/2021 - 07/2016
3	Angiotensin Receptor AntagonistsIBA 01/2021 - 05/2016
3	atezolizumabIBA 01/2021 - 01/2020
3	Blood Proteins (Serum Proteins)IBA 10/2020 - 01/2016
3	omega-N-Methylarginine (NG Monomethyl L Arginine)IBA 01/2019 - 06/2013
3	Cardiovascular AgentsIBA 01/2019 - 01/2005
3	symmetric dimethylarginineIBA 01/2016 - 08/2008
3	AldosteroneIBA 09/2013 - 06/2006
3	Cyclooxygenase 2 Inhibitors (COX-2 Inhibitors)IBA 09/2013 - 05/2010
2	Oxygen (Dioxygen)IBA 11/2022 - 11/2021
2	Hydroxychloroquine (Plaquenil)FDA LinkGeneric 06/2022 - 01/2021
2	Alanine Transaminase (SGPT)IBA 01/2022 - 01/2021
2	MB Form Creatine KinaseIBA 01/2022 - 09/2021
2	Protein Isoforms (Isoforms)IBA 10/2021 - 05/2016
2	fibrin fragment D (D-dimer)IBA 09/2021 - 04/2003
2	pirfenidoneIBA 01/2021 - 10/2020
2	Complement System Proteins (Complement)IBA 01/2021 - 01/2018
2	CholesterolIBA 01/2021 - 09/2016
2	nintedanibIBA 01/2021 - 10/2020
2	Cysteine (L-Cysteine)FDA Link 10/2020 - 05/2020
2	Glycated Hemoglobin (Glycosylated Hemoglobin)IBA 01/2020 - 01/2005
2	Immune Checkpoint InhibitorsIBA 01/2020 - 01/2020
2	Omega-3 Fatty Acids (Omega 3 Fatty Acids)IBA 01/2019 - 01/2019
2	Sunitinib (Sutent)FDA Link 01/2018 - 01/2016
2	pazopanib FDA Link 01/2018 - 01/2016

Therapy/Procedure

15	Therapeutics 07/2022 - 05/2002
3	Drug Therapy (Chemotherapy) 11/2022 - 01/2002
3	Polypharmacy 01/2021 - 12/2016
2	Artificial Respiration (Mechanical Ventilation) 06/2022 - 01/2021
2	Length of Stay 06/2022 - 08/2013
2	Enteral Nutrition (Feeding, Tube) 01/2021 - 01/2020
2	Patient Readmission 01/2021 - 10/2018
2	Institutionalization (Institutionalized Persons) 10/2019 - 10/2011